| 摘要 |
Inhibitors of cPLA<SUB>2</SUB>a expression are used in the preparation of pharmaceutical compositions for the inhibition of cancer cell proliferation and for the treatment of cancer; the inhibitors are selected from cPLA<SUB>2</SUB>a -specific ribozymes, RNA sequences usable for RNA-interference of the cPLA<SUB>2</SUB>a gene, and antisense oligonucleotides directed against cPLA<SUB>2</SUB>a. |
